|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
IRCT |
|
Last refreshed on:
|
22 February 2018 |
|
Main ID: |
IRCT2014123118866N4 |
|
Date of registration:
|
2015-02-15 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Evaluation of prophylactic salpingectomy on ovarian function
|
|
Scientific title:
|
Evaluation of prophylactic salpingectomy on ovarian function in patients undergo hysterectomy by laparascopic & laparatomy in Arash hospital |
|
Date of first enrolment:
|
2014-11-22 |
|
Target sample size:
|
40 |
|
Recruitment status: |
Complete |
|
URL:
|
http://en.irct.ir/trial/16999 |
|
Study type:
|
interventional |
|
Study design:
|
Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Iran (Islamic Republic of)
| | | | | | | |
|
Contacts
|
|
Name:
|
Dr. Afsaneh Tehranian
|
|
Address:
|
Arash women hospital, Tehranpars, Resalat highway
Tehran
Iran (Islamic Republic of) |
|
Telephone:
|
+98 21 7788 3283 |
|
Email:
|
afsanehtehranian@yahoo.com |
|
Affiliation:
|
Tehran University of Medical Sciences |
|
|
Name:
|
Dr. Roghieh Hasani
|
|
Address:
|
Arash women hospital, Tehranpars, Resalat highway
Tehran
Iran (Islamic Republic of) |
|
Telephone:
|
+98 21 7788 3283 |
|
Email:
|
somayesaat_hidary@yahoo.com |
|
Affiliation:
|
Tehran University of Medical Sciences |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Inclusion criteria: women aged 18-45 years old, candidates for hysterectomy and not oopherectomy; no menopause symptoms; FSH<10 IU.
Exclusion criteria: history of pelvic surgery; existence of ovarian mass in sonography before the surgery; smoking; OCP consumption at least for 6 months.
Exclusion criteria:
Age minimum:
18 years
Age maximum:
45 years
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Irregular menstruation, unspecified
|
Uterine bleeding.
Irregular menstruation, unspecified
|
|
Intervention(s)
|
|
Second group: the patient undergoes only hysterectomy.
|
|
First group: the patient undergoes hysterectomy and salpangectomy.
|
|
Intervention 1: First group: the patient undergoes hysterectomy and salpangectomy. Intervention 2: Second group: the patient undergoes only hysterectomy.
|
|
Treatment - Surgery
|
|
Primary Outcome(s)
|
|
Serum anti-mullerian hormone level. Timepoint: Before surgery and 3 months after it. Method of measurement: Blood test.
|
|
FSH serum level. Timepoint: Before surgery and 3 moths after t. Method of measurement: Blood test.
|
|
Source(s) of Monetary Support
|
|
Vice chancellor for research, Tehran University of Medical Sciences
|
|
Ethics review
|
Status: Approved
Approval date:
Contact:
Ethics Committee of Tehran University of Medical Science
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|